{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T03:19:10Z","timestamp":1764645550090,"version":"3.41.2"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,16]]},"DOI":"10.1093\/braincomms\/fcaa229","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T04:01:58Z","timestamp":1610337718000},"source":"Crossref","is-referenced-by-count":6,"title":["Response to: \u2018Nodding syndrome, many questions remain but we can prevent it by eliminating onchocerciasis\u2019"],"prefix":"10.1093","volume":"3","author":[{"given":"Sam","family":"Olum","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Gulu University, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Scolding","sequence":"additional","affiliation":[{"name":"Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Hardy","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Gulu University, Uganda"},{"name":"Royal United Hospital, Bath, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Obol","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Gulu University, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil J","family":"Scolding","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Gulu University, Uganda"},{"name":"Institute of Clinical Neurosciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"2021011707244416800_fcaa229-B1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1475-2883-2-S1-S4","article-title":"Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon","volume":"2","author":"Boussinesq","year":"2003","journal-title":"Filaria J"},{"key":"2021011707244416800_fcaa229-B2","doi-asserted-by":"crossref","first-page":"17073","DOI":"10.1038\/s41598-020-74084-y","article-title":"Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats","volume":"10","author":"Chaccour","year":"2020","journal-title":"Sci Rep"},{"key":"2021011707244416800_fcaa229-B3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/epi4.12054","article-title":"Onchocerciasis-associated epilepsy: from recent epidemiological and clinical findings to policy implications","volume":"2","author":"Colebunders","year":"2017","journal-title":"Epilepsia Open"},{"key":"2021011707244416800_fcaa229-B4","doi-asserted-by":"crossref","first-page":"e0007407","DOI":"10.1371\/journal.pntd.0007407","article-title":"From river blindness to river epilepsy: implications for onchocerciasis elimination programmes","volume":"13","author":"Colebunders","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2021011707244416800_fcaa229-B5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S1473-3099(20)30122-5","article-title":"Changes in epilepsy burden after onchocerciasis elimination in a hyperendemic focus of western Uganda: a comparison of two population-based, cross-sectional studies","volume":"20","author":"Gumisiriza","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2021011707244416800_fcaa229-B6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40249-020-0628-3","article-title":"Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures","volume":"9","author":"Gumisiriza","year":"2020","journal-title":"Infect Dis Poverty"},{"journal-title":"Brain Commun","article-title":"Nodding syndrome, many questions remain but we can prevent it by eliminating onchocerciasis","author":"Gumisiriza","key":"2021011707244416800_fcaa229-B7"},{"key":"2021011707244416800_fcaa229-B8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijid.2019.11.029","article-title":"Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy","volume":"91","author":"Hotterbeekx","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2021011707244416800_fcaa229-B9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6953","article-title":"Nodding syndrome may be an autoimmune reaction to the parasitic worm Onchocerca volvulus","author":"Johnson","year":"2017","journal-title":"Sci Transl Med"},{"key":"2021011707244416800_fcaa229-B10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0378-4274(91)90143-T","article-title":"Modulation of monomethylhydrazine-induced seizures by ivermectin","volume":"57","author":"Mayer","year":"1991","journal-title":"Toxicol Lett"},{"key":"2021011707244416800_fcaa229-B11","doi-asserted-by":"crossref","first-page":"fcaa037","DOI":"10.1093\/braincomms\/fcaa037","article-title":"Nodding syndrome: a concise review","volume":"2","author":"Olum","year":"2020","journal-title":"Brain Commun"},{"key":"2021011707244416800_fcaa229-B12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pt.2014.07.005","article-title":"Ivermectin: panacea for resource-poor communities?","volume":"30","author":"\u014cmura","year":"2014","journal-title":"Trends Parasitol"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/braincomms\/article-pdf\/3\/1\/fcaa229\/35907047\/fcaa229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/braincomms\/article-pdf\/3\/1\/fcaa229\/35907047\/fcaa229.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T12:25:01Z","timestamp":1610886301000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcaa229\/6066625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,16]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcaa229","relation":{},"ISSN":["2632-1297"],"issn-type":[{"type":"electronic","value":"2632-1297"}],"subject":[],"published-other":{"date-parts":[[2021]]},"published":{"date-parts":[[2021]]},"article-number":"fcaa229"}}